Tech Company Financing Transactions
BlueWhale Bio Funding Round
BlueWhale Bio secured a $18 million investment round on 9/8/2023. Investors included Danaher Ventures LLC, Marshall Wace and Novalis LifeSciences.
Transaction Overview
Company Name
Announced On
9/8/2023
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Philadelphia, PA Undisclosed
USA
Philadelphia, PA Undisclosed
USA
Phone
Undisclosed
Email Address
Overview
Developer of cell drugs intended to overcome bottlenecks in gene therapy manufacturing. The company specializes in developing cell therapy to treat cancer, enabling patients to attain effective cancer treatment plans.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Keller
Browse more venture capital transactions:
Prev: 9/8/2023: BFC venture capital transaction
Next: 9/8/2023: Brine Fi venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs